¼¼°èÀÇ ¼Òº¯ºÐ¼®±â ½ÃÀå
Urometers
»óǰÄÚµå : 1784811
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 275 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,150,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,452,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼Òº¯ºÐ¼®±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 7¾ï 2,360¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 5¾ï 4,900¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼Òº¯ºÐ¼®±â ¼¼°è ½ÃÀåÀº 2030³â¿¡´Â 7¾ï 2,360¸¸ ´Þ·¯¿¡ ´ÞÇϰí, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 4.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼ö¼ú ÀýÂ÷´Â CAGR 4.2%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 3¾ï 5,310¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÀ±Þ ¿Ü»ó ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 4,960¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼Òº¯ºÐ¼®±â ½ÃÀåÀº 2024³â¿¡ 1¾ï 4,960¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 7.4%·Î 2030³â±îÁö 1¾ï 4,150¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 2.3%¿Í 4.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼Òº¯ºÐ¼®±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Á¤È®ÇÑ Ã¼¾× ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¼Òº¯ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡?

ÁßȯÀÚ½Ç È¯°æ¿¡¼­ÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ¹× ü¾× ±ÕÇü °ü¸®¿¡ ´ëÇÑ Àü ¼¼°èÀÇ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó, ¼Òº¯ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °íÁ¤¹Ð ¿ä·® ÃøÁ¤ ÀåÄ¡´Â ÁßȯÀÚ½Ç(ICU), ¼ö¼ú ÈÄ È¸º¹½Ç, ÀÀ±Þ½Ç, ¼ö¼ú½Ç µî¿¡¼­ ½ÅÀå ±â´É ¹× ü¾× »óŸ¦ ¸ð´ÏÅ͸µÇϱâ À§ÇØ ½Ç½Ã°£ ¿ä·® µ¥ÀÌÅͰ¡ ÇʼöÀûÀÔ´Ï´Ù. ±Þ¼º½ÅÀå¾Ö(AKI), ÆÐÇ÷Áõ, ´ë¼ö¼ú, ¿Ü»ó µîÀÇ °æ¿ì ¸é¹ÐÇÑ Ã¼¾× ÃßÀûÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹À¸¸ç, °íµµÀÇ ±Þ¼º±â ÀÓ»ó ÇöÀå¿¡¼­´Â ¿ä·Î°è°¡ ÇʼöÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °íÇ÷¾Ð, ´ç´¢º´, ½ÉÀ庴 µî ½ÅÀå ±â´É Àå¾ÖÀÇ À§ÇèÀ» ³ôÀÌ´Â ¸¸¼ºÁúȯÀÇ Áõ°¡·Î ÀÎÇØ Ä¡·á ¹æÄ§À» °áÁ¤Çϱâ À§ÇÑ Á¤È®ÇÑ ¿ä·® ÃøÁ¤¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è °í·ÉÈ­·Î ÀÎÇØ ¿äµµ Ä«Å×ÅÍ °Ë»ç ¹× ¿ä·® ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ È¯ÀÚ ¼ö°¡ Áõ°¡Çϰí ÀÖ¾î ¾ÈÁ¤ÀûÀÎ ¼ö¿ä ±â¹ÝÀÌ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. º´¿ø°ú ¼ö¼ú ¼¾ÅÍ´Â Á¤¹Ð Áø´Ü°ú Á¶±â °³ÀÔ Àü·«À» Áß½ÃÇϰí ÀÖÀ¸¸ç, ¼Òº¯ºÐ¼®±â¿Í °°Àº ±â±âÀÇ Á߿伺ÀÌ ´õ¿í °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·áÁøÀº ¼ö¾× °ú´Ù, Å»¼ö, ÀüÇØÁú ºÒ±ÕÇü°ú °°Àº ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ °³Àκ° ¸ÂÃã ¼ö¾× ¿ä¹ýÀ» ¾È³»ÇÏ´Â ¼Òº¯ºÐ¼®±âÀÇ ¿ªÇÒÀÌ ÀÓ»óÀûÀ¸·Î Áß¿äÇØÁö¸é¼­ ±ÔÁ¦ ´ç±¹ÀÇ ÁÖ¸ñÀ» ¹Þ°í ÀÖ½À´Ï´Ù.

µðÀÚÀÎ Çõ½Å°ú °¨¿° Á¦¾îÀÇ ¿ä±¸´Â ¾î¶»°Ô Çö´ë ¼Òº¯ºÐ¼®±â¸¦ Çü¼ºÇϰí Àִ°¡?

Â÷¼¼´ë ¼Òº¯ºÐ¼®±âÀÇ ¼³°è ¹× °³¹ß¿¡¼­ °¨¿° ¿¹¹æ°ú ȯÀÚ ¾ÈÀüÀÌ ÁÖ¿ä °í·Á»çÇ×ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ¼Òº¯ ÃøÁ¤ ½Ã½ºÅÛÀº ±³Â÷ ¿À¿° ¹× Ä«Å×ÅÍ °ü·Ã ¿ä·Î°¨¿°(CAUTI)ÀÇ À§ÇèÀÌ Àֱ⠶§¹®¿¡ Á¦Á¶¾÷üµéÀº ³ëÃâÀ» ÃÖ¼ÒÈ­ÇÏ°í ¹è¾× È¿À²À» Çâ»ó½ÃŰ´Â Æó¼âÇü ½Ã½ºÅÛ ¼Òº¯ºÐ¼®±â·Î Çõ½ÅÀ» ²ÒÇϰí ÀÖ½À´Ï´Ù. ¿ª·ù ¹æÁö ¹ëºê, ´Ïµé¸®½º »ùÇøµ Æ÷Æ®, Ç×±Õ ÄÚÆÃ°ú °°Àº ±â´ÉÀº ÀÇ·áÁøÀÇ »ç¿ë ÆíÀǼºÀ» À¯ÁöÇϸ鼭 °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇØ µµÀԵǾú½À´Ï´Ù. ¶ÇÇÑ, ´õ Å« µð½ºÇ÷¹ÀÌ Ã¢, ¿ª·ù ¹æÁö, Á¤¹ÐÇÑ ±³Á¤ µî ÀÎü°øÇÐÀû ¼³°è¸¦ ÅëÇØ ÃÖ½ÅÀÇ ¼Òº¯ºÐ¼®±â´Â ´õ¿í »ç¿ëÇϱ⠽±°í, ´õ¿í Á¤È®ÇØÁ³½À´Ï´Ù. ƯÈ÷ ÁßȯÀÚ½ÇÀ̳ª ¼ö¼ú½Ç°ú °°ÀÌ °¨¿° À§ÇèÀÌ ³ôÀº ȯ°æ¿¡¼­ ÀÏȸ¿ë ÀÏȸ¿ë ÀÏȸ¿ë ¼Òº¯°èÀÇ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ »Ó¸¸ ¾Æ´Ï¶ó º´¿øÀÇ °¨¿° °ü¸® ÇÁ·ÎÅäÄÝ ¹× ±ÔÁ¦ ±âÁØ Áؼö¸¦ Áö¿øÇÕ´Ï´Ù. ÀÌ¿Í ÇÔ²² ¶óÅØ½º ÇÁ¸®, BPA ÇÁ¸® ÇÃ¶ó½ºÆ½ µî ¼ÒÀçÀÇ °³¼±À¸·Î »ýüÀûÇÕ¼º°ú Àå±â »ç¿ëÀÇ ¾ÈÀü¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ä«Å×ÅÍ ½Ã½ºÅÛ ¹× º£µå ¾îÅÂÄ¡¸ÕÆ®¿ÍÀÇ ÅëÇÕÀ» ¿ëÀÌÇÏ°Ô Çϰí ȯÀÚ À̵¿ ½Ã È¥¶õÀ» ÁÙÀÏ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ µðÀÚÀÎ ¹× ±â´ÉÀÇ ¹ßÀüÀ¸·Î ¼Òº¯ºÐ¼®±â´Â ´Ü¼øÇÑ ÃøÁ¤ µµ±¸¿¡¼­ ÷´Ü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ Áß¿äÇÑ ±¸¼º¿ä¼Ò·Î º¯¸ðÇϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ ÅëÇÕ°ú ½º¸¶Æ® ¸ð´ÏÅ͸µÀÌ ¼Òº¯ºÐ¼®±âÀÇ Çõ½ÅÀ» ÃËÁøÇÒ ¼ö ÀÖÀ»±î?

ü¾× ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ µðÁöÅÐ ±â¼úÀ» ÅëÇÕÇÏ¿© Àü ¼¼°è ¼Òº¯ºÐ¼®±â ½ÃÀåÀ» ºü¸£°Ô Çö´ëÈ­Çϰí ÀÖ½À´Ï´Ù. º´¿ø°ú Áø·á¼Ò¿¡¼­´Â °£È£ ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÏ°í ¼öÀÛ¾÷À¸·Î ÀÎÇÑ ½Ç¼ö °¡´É¼ºÀ» ÁÙÀ̱â À§ÇØ µðÁöÅÐ ¼¾¼­, ¹«¼± µ¥ÀÌÅÍ Àü¼Û, ÀÚµ¿ Ãâ·Â ±â·Ï ±â´ÉÀ» °®Ãá ½º¸¶Æ® À¯·®°è¸¦ Á¡Á¡ ´õ ¸¹ÀÌ Ã¤ÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µðÁöÅÐ ½Ã½ºÅÛÀº ÀüÀÚ ÀÇ·á ±â·Ï(EHR)¿¡ ÀÚµ¿À¸·Î ¿¬°áµÉ ¼ö ÀÖ´Â ¿¬¼ÓÀûÀÎ ½Ç½Ã°£ ¼Òº¯ ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÏ¿© º¸´Ù Àû½Ã¿¡ °³ÀÔÇϰí ÃßÀ̸¦ ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁßȯÀÚ Ä¡·á³ª ÀÌ½Ä ÈÄ ¸ð´ÏÅ͸µ°ú °°Àº ±ä±ÞÇÑ È¯°æ¿¡¼­ ÀÌ·¯ÇÑ Çõ½ÅÀº ÀÓ»óÀÇ¿¡°Ô ½ÅÀå ±â´É°ú ü¾× ±ÕÇü¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÔÀ¸·Î½á ºó¹øÇÑ ¼öÀÛ¾÷ È®ÀÎ ¾øÀ̵µ ½ÅÀå ±â´É°ú ü¾× ±ÕÇü¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀϺΠ½º¸¶Æ® À¯·®°è´Â Ãâ·Â ÀÌ»ó, ¸·Èû ¶Ç´Â ½Ã½ºÅÛ °íÀå °¡´É¼ºÀ» Á÷¿ø¿¡°Ô ¾Ë·ÁÁÖ´Â °æ°í ½Ã½ºÅÛµµ °®Ãß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´ÉÀº Áß¾Ó ¸ð´ÏÅ͸µ ½ºÅ×À̼ÇÀÌ ¿©·¯ ȯÀÚ¸¦ ¸ð´ÏÅ͸µÇÏ´Â ¿ø°ÝÁö³ª ¿ø°Ý ICU ȯ°æ¿¡¼­ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¶ÇÇÑ, »ç¹°ÀÎÅͳÝ(IoT)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕÀº ¼ö¾× °ü¸®¿¡¼­ ¿¹Ãø ºÐ¼®ÀÇ ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ µðÁöÅÐÈ­µÈ µ¥ÀÌÅÍ ±â¹Ý Áø·á ¸ðµ¨·Î ÀüȯÇϰí ÀÖ´Â °¡¿îµ¥, ¼Òº¯ °Ë»ç¿Í µðÁöÅÐ °Ç°­ »ýŰèÀÇ À¶ÇÕÀº Çõ½Å, È¿À²¼º, ȯÀÚ °á°ú °³¼±À» À§ÇÑ »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº º´¿øÀÌ ¿î¿µ ¿ì¼ö¼º ¹× ÀÓ»ó ǰÁú ÁöÇ¥¿¡ ´ëÇÑ ¸ñÇ¥¸¦ ´Þ¼ºÇÏ´Â µ¥¿¡µµ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.

Àü ¼¼°è ¼Òº¯ºÐ¼®±â ½ÃÀåÀÇ Àå±âÀûÀÎ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¼Òº¯ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀº Àα¸ µ¿Çâ, ÀÓ»óÀû ¿ä±¸, ±â¼ú Çõ½Å, ÁøÈ­ÇÏ´Â ÀÇ·á Ç¥ÁØ µî ´Ù¾çÇÑ ¿äÀÎÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ¸¸¼º ½ÅÀå Áúȯ(CKD), ÆÐÇ÷Áõ, ½ÉºÎÀü, ü¾× ±ÕÇüÀÌ È¯ÀÚ °ü¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¼ö¼ú ÈÄ È¸º¹ ½Ã³ª¸®¿À¿Í °°Àº ¼¼°è ºÎ´ãÀÇ Áõ°¡ÀÔ´Ï´Ù. ƯÈ÷ ½ÅÈï½ÃÀå¿¡¼­´Â ÁýÁßÄ¡·á ÀÎÇÁ¶óÀÇ µµÀÔÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¼Òº¯·® ¸ð´ÏÅ͸µ ÀåºñÀÇ ¼³Ä¡ ±â¹ÝÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. µ¿½Ã¿¡, ƯÈ÷ ¼±Áø±¹À» Áß½ÉÀ¸·Î Àü ¼¼°èÀûÀ¸·Î °í·ÉÈ­°¡ ÁøÇàµÇ¸é¼­ Ä«Å×ÅÍ Ä¡·á¿Í ü¾× °ü¸®ÀÇ Çʿ伺ÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. º´¿ø°ú ÀÇ·á ½Ã½ºÅÛ¿¡¼­´Â AKI, ¿äÆó µîÀÇ ÇÕº´ÁõÀ» Á¶±â¿¡ ¹ß°ßÇÏ´Â °ÍÀÌ Áß¿äÇØÁö¸é¼­ ¿Ü°ú º´µ¿À̳ª ³»°ú º´µ¿¿¡¼­ ¼Òº¯ºÐ¼®±â°¡ ÀÏ»óÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¨¿° °ü¸® ¹× Ä«Å×ÅÍ °ü·Ã ÇÁ·ÎÅäÄÝ¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ °¨½Ã°¡ °­È­µÇ¸é¼­ Æó¼âÇü ½Ã½ºÅÛ, Ç×±Õ, ÀÏȸ¿ë ¼Òº¯ºÐ¼®±â ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÇ µðÁöÅÐÈ­¿Í °¡Ä¡ ±â¹Ý Áø·á ¸ðµ¨·ÎÀÇ ÀüȯÀº °£È£ ½Ã°£°ú º´¿ø ÀÚ¿øÀ» ÃÖÀûÈ­Çϰí ÀÓ»ó °á°ú¸¦ °³¼±ÇÏ´Â ½º¸¶Æ® ÀÇ·á±â±â µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀϺΠ½ÃÀå¿¡¼­ÀÇ ÀçÅÃÀÇ·á ¼­ºñ½º ÀÌ¿ë °¡´É¼ºÀÇ È®´ë¿Í ÁßȯÀÚ Ä¡·á ¿ëǰ¿¡ ´ëÇÑ »óȯ Àû¿ëµµ ½ÃÀå ħÅõ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨ÀÌ ÁøÈ­Çϰí Á¤È®ÇÑ ½Ç½Ã°£ ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ Çʿ伺ÀÌ Á¡Á¡ ´õ Ä¿Áö°í ÀÖ´Â °¡¿îµ¥, ÀÌ·¯ÇÑ ¿äÀεéÀÌ Á¾ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¼¼°è ¼Òº¯ºÐ¼®±â ½ÃÀåÀÇ °ß°íÇϰí Áö¼ÓÀûÀÎ ¼ºÀåÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(¼ö¼ú, ÀÀ±Þ ¿Ü»ó, ¿ÏÈ­ÀÇ·á, ±âŸ), ÃÖÁ¾ ¿ëµµ(º´¿ø, Áø·á¼Ò, ÀçÅà ÇコÄɾî, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Urometers Market to Reach US$723.6 Million by 2030

The global market for Urometers estimated at US$549.0 Million in the year 2024, is expected to reach US$723.6 Million by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Operative Procedures, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$353.1 Million by the end of the analysis period. Growth in the Emergency Trauma segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$149.6 Million While China is Forecast to Grow at 7.4% CAGR

The Urometers market in the U.S. is estimated at US$149.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$141.5 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Urometers Market - Key Trends & Drivers Summarized

Is the Growing Focus on Accurate Fluid Monitoring Boosting Demand for Urometers?

The increasing global focus on patient monitoring and fluid balance management in critical care settings is significantly driving demand for urometers. These precision urine output measurement devices are essential in intensive care units (ICUs), post-operative recovery wards, emergency departments, and operating rooms where real-time urine volume data is critical for monitoring kidney function and fluid status. Acute kidney injury (AKI), sepsis, major surgeries, and trauma cases often require meticulous fluid tracking, making urometers indispensable in high-acuity clinical scenarios. The rise in chronic diseases such as hypertension, diabetes, and cardiac disorders-conditions that heighten the risk of renal impairment-has led to a greater reliance on accurate urine output measurement to guide treatment decisions. Additionally, the aging global population is increasing the volume of patients needing urinary catheterization and output monitoring, creating a stable demand base. Hospitals and surgical centers are emphasizing precision diagnostics and early intervention strategies, which further underscore the importance of devices like urometers. As healthcare providers aim to minimize complications such as fluid overload, dehydration, and electrolyte imbalance, the role of urometers in guiding personalized fluid therapy is gaining greater clinical significance and regulatory attention.

How Are Design Innovations and Infection Control Needs Shaping the Modern Urometer?

Infection prevention and patient safety are becoming key considerations in the design and development of next-generation urometers. Traditional urine measurement systems pose risks of cross-contamination and catheter-associated urinary tract infections (CAUTIs), leading manufacturers to innovate with closed-system urometers that minimize exposure and improve drainage efficiency. Features like anti-reflux valves, needleless sampling ports, and antimicrobial coatings are being incorporated to reduce infection risks while maintaining ease of use for healthcare staff. Additionally, ergonomic designs with larger display windows, backflow prevention, and precision calibration are making modern urometers more user-friendly and accurate. The demand for disposable, single-use urometers is also increasing, especially in high-infection-risk environments such as ICUs and surgical theaters. These innovations not only enhance patient outcomes but also support compliance with hospital infection control protocols and regulatory standards. In parallel, improvements in materials-such as latex-free and BPA-free plastics-are enhancing biocompatibility and safety for long-term use. Urometers are also being designed for easier integration with catheter systems and bed attachments, reducing disruption during patient movement. Collectively, these design and functional advancements are transforming the urometer from a simple measurement tool into a critical component of advanced patient monitoring systems.

Can Digital Integration and Smart Monitoring Propel Urometer Innovation?

The integration of digital technologies into fluid monitoring systems is rapidly modernizing the global urometer market. Hospitals and clinics are increasingly adopting smart urometers equipped with digital sensors, wireless data transmission, and automated output recording to streamline nursing workflows and reduce the potential for manual error. These digital systems allow for continuous, real-time urine monitoring that can be automatically linked to electronic health records (EHRs), enabling more timely interventions and trend analysis. In high-acuity settings such as critical care or post-transplant monitoring, these innovations provide clinicians with valuable insights into renal function and fluid balance without the need for frequent manual checks. Some smart urometers even feature alert systems that notify staff of abnormalities in output, blockages, or possible system malfunctions. These capabilities are particularly useful in remote and tele-ICU settings, where central monitoring stations oversee multiple patients. Furthermore, the integration of IoT (Internet of Things) and machine learning algorithms holds potential for predictive analytics in fluid management. As healthcare systems worldwide shift toward digitized and data-driven models of care, the convergence of urometry with digital health ecosystems is creating new opportunities for innovation, efficiency, and improved patient outcomes. These advancements are also helping hospitals meet their goals around operational excellence and clinical quality metrics.

What Factors Are Driving the Long-Term Growth of the Urometer Market Globally?

The growth in the urometer market is driven by a multifaceted combination of demographic trends, clinical needs, technological innovation, and evolving healthcare standards. One of the core growth drivers is the rising global burden of chronic kidney disease (CKD), sepsis, heart failure, and post-surgical recovery scenarios where fluid balance plays a critical role in patient management. The increasing adoption of intensive care infrastructure-particularly in emerging markets-is expanding the installed base of urinary output monitoring devices. Simultaneously, the aging global population, particularly in developed countries, is leading to a surge in catheterization procedures and fluid management requirements. Hospitals and health systems are placing a stronger emphasis on early detection of complications such as AKI and urinary retention, fueling the routine use of urometers in surgical and medical wards. Additionally, heightened regulatory scrutiny around infection control and catheter-related protocols is pushing demand for closed-system, antimicrobial, and single-use urometer solutions. The ongoing digitization of healthcare delivery and the move toward value-based care models are also supporting the adoption of smart urometers that improve clinical outcomes while optimizing nursing time and hospital resources. Reimbursement coverage for critical care supplies and the expanding availability of home healthcare services in select markets are also contributing to market penetration. As healthcare delivery models evolve and the need for accurate, real-time patient monitoring becomes increasingly essential, these forces are collectively ensuring robust, sustained growth for the global urometer market.

SCOPE OF STUDY:

The report analyzes the Urometers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Operative Procedures, Emergency Trauma, Palliative Care, Others); End-Use (Hospital, Clinics, Home Healthcare, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â